Nuvectis Hosts KOL on NXP900 Phase 1b Trial in Advanced Tumors
25 Nov 2025 //
GLOBENEWSWIRE
Nuvectis Pharma Provides Poster Presentation Highlight for NXP900
27 Oct 2025 //
GLOBENEWSWIRE
Nuvectis Pharma To Present NXP900 At 2025 Cancer Therapeutics
16 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support